All Roll Calls
Yes: 248 • No: 0
Sponsored By: Michelle Lopes Maldonado (Democratic)
Became Law
Health insurance; carrier contracts; required provisions regarding prior authorization for prescription drugs. Amends existing required provisions for health carrier contracts related to prior authorizations for prescription drugs. Current law requires that if prior authorization is approved for prescription drugs and such prescription drugs have been scheduled, provided, or delivered to the patient consistent with the authorization, health carriers may not revoke, limit, condition, modify, or restrict that authorization except in certain circumstances. The bill requires this limitation on carriers to apply for the duration of the authorization, which the bill requires to be a minimum of six months for initial authorizations and a minimum of 12 months for continued authorizations. The bill adds circumstances under which a prior authorization may be revoked, limited, conditioned, modified, or restricted by a carrier, including (i) a final action by the U.S. Food and Drug Administration, other regulatory agencies, or the manufacturer communicating a patient efficacy issue that would affect the authorization and (ii) when additional safety and efficacy monitoring is clinically appropriate or recommended by the U.S. Food and Drug Administration, other regulatory agencies, or the manufacturer.
Personalized for You
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
5 provisions identified: 3 benefits, 1 costs, 1 mixed.
Beginning January 1, 2027, these prior authorization protections do not apply to Medicare, Medicaid, CHIP, federal employee plans, TRICARE, many supplemental or specialty plans, workers’ compensation, dental and vision plans, and some HMOs that meet strict conditions (including processing at least 85% of drug approvals interoperably). If you are in these plans, these rules do not apply. The Commission cannot decide individual disputes under this section; you must use other legal or administrative paths.
Beginning January 1, 2027, at least one covered medication for substance use disorder is available without prior authorization if the dose follows FDA limits and the prescription follows Board of Medicine rules. For mental health drugs listed in the DSM, no new approval is required if the drug is covered, the dose follows FDA limits, it has been prescribed for at least three months, and the prescriber reviews it yearly. If you already have approval and the plan later drops the drug from the formulary, the approval still stands when those conditions are met. Plans may still require approval for drugs that were not on the formulary at the first prescription.
Beginning January 1, 2027, insurers must accept prior authorization requests by phone, fax, and from e‑prescribing/EHR systems that use the NCPDP SCRIPT standard. Urgent requests get a response within 24 hours (including weekends). Fully completed requests get a response in two business days; properly completed supplements also get a decision in two business days. Denials must state the reasons within the same time limits. Insurers must use a tracking system and share the tracking ID with the prescriber. They must post the drug formulary, which drugs need approval, the approval steps, and forms in one place online and update it within seven days of approved changes. If extra health‑record information is needed, the insurer must name the exact records. These rules apply to contracts dated January 1, 2016 or later.
Beginning January 1, 2027, an approved prior authorization lasts at least six months for an initial approval and at least 12 months for a continued approval. Insurers cannot revoke or change an approval during that time unless there is fraud, new FDA or manufacturer safety actions, needed safety monitoring, harmful drug interactions, or when a generic or biosimilar is added. If you switch plans within the same insurer, your approval stays valid when the new plan covers the drug. If you move to a new insurer, the new plan must honor a prior approval from your last plan for at least the first 90 days when your prescriber sends proof. If a non‑opioid drug dose changes within FDA labeling, the prior authorization still stands.
By July 1, 2025, insurers must run an online prior authorization system that links to e‑prescribing and EHRs, accepts electronic requests, can auto‑approve simple requests, and shows your real‑time out‑of‑pocket price and lower‑cost options. Insurers cannot charge providers to use it and cannot access provider data beyond enrollee information without consent. By July 1, 2024, insurers must post contact information for any third‑party vendor they use. By July 1, 2025, participating providers must enable their e‑prescribing/EHR systems to use the insurer’s online approvals and real‑time benefits at prescribing; a temporary hardship waiver is available.
Michelle Lopes Maldonado
Democratic • House
There are no cosponsors for this bill.
All Roll Calls
Yes: 248 • No: 0
Senate vote • 3/5/2026
Passed Senate Block Vote
Yes: 39 • No: 0
Senate vote • 3/4/2026
Passed by for the day Block Vote (Voice Vote)
Yes: 0 • No: 0
Senate vote • 3/4/2026
Constitutional reading dispensed Block Vote (on 2nd reading)
Yes: 39 • No: 0
Senate vote • 3/2/2026
Reported from Commerce and Labor
Yes: 13 • No: 0
House vote • 2/17/2026
Read third time and passed House Block Vote
Yes: 97 • No: 0
House vote • 2/13/2026
Reported from Appropriations
Yes: 22 • No: 0
House vote • 2/13/2026
Subcommittee recommends reporting
Yes: 7 • No: 0 • Other: 1
House vote • 2/5/2026
Reported from Labor and Commerce with amendment(s) and referred to Appropriations
Yes: 22 • No: 0
House vote • 2/3/2026
Subcommittee recommends reporting with amendment(s) and referring to Appropriations
Yes: 9 • No: 0 • Other: 1
Acts of Assembly Chapter text (CHAP0213)
Approved by Governor-Chapter 213 (effective 7/1/2026)
Governor's Action Deadline 11:59 p.m., April 13, 2026
Enrolled Bill communicated to Governor on March 14, 2026
Bill text as passed House and Senate (HB736ER)
Enrolled
Fiscal Impact Statement from Department of Planning and Budget (HB736)
Signed by President
Signed by Speaker
Passed Senate Block Vote (39-Y 0-N 0-A)
Read third time
Passed by for the day Block Vote (Voice Vote)
Constitutional reading dispensed Block Vote (on 2nd reading) (39-Y 0-N 0-A)
Rules suspended
Reported from Commerce and Labor (13-Y 0-N)
Referred to Committee on Commerce and Labor
Constitutional reading dispensed (on 1st reading)
Read third time and passed House Block Vote (97-Y 0-N 0-A)
Fiscal Impact Statement from Department of Planning and Budget (HB736)
Engrossed by House as amended
committee amendments agreed to
Read second time
Read first time
Subcommittee recommends reporting (7-Y 0-N)
Reported from Appropriations (22-Y 0-N)
Chaptered
4/6/2026
Enrolled
3/9/2026
Engrossed
2/16/2026
Amendment
2/5/2026
Amendment
2/4/2026
Introduced
1/13/2026
SB767 — Motor vehicles; glass repair and replacement, emissions inspections, penalties, repeals.
Motor vehicle glass repair and replacement; emissions inspection; penalties. Establishes various notice requirements for motor vehicle glass repair shops, defined in the bill, and provides that a violation of such requirements is a prohibited practice under the Virginia Consumer Protection Act. The bill permits a motor vehicle to qualify for an emissions inspection waiver if such vehicle has failed an inspection and the vehicle's onboard diagnostic system is in a not-ready condition to be tested when presented for reinspection. This bill is identical to HB 312.
SB803 — Virginia Fair Housing Law; regulations defining terms related to unlawful conduct.
Virginia Fair Housing Law; unlawful conduct. Directs the Fair Housing Board to promulgate regulations defining "quid pro quo harassment," "hostile environment harassment," and other terms related to unlawful conduct under the Virginia Fair Housing Law. The bill directs the Fair Housing Board to adopt emergency regulations to implement the provisions of the bill.
SB731 — Private companies providing public transportation services; employee protections.
Private companies providing public transportation services; employee protections; report. Requires the governing body of any county or city that contracts with a private company to provide transportation services to (i) require such company to provide any employee of such company providing such services compensation and benefits that are, at a minimum, equivalent to the compensation and benefits provided to a public employee, as defined in the bill, with a position requiring equivalent qualifications and years of service; (ii) provide transportation services through such company's own employees; and (iii) if such county or city subsequently elects to provide its own system of public transportation, adopt an ordinance or resolution providing for collective bargaining and ensure all employees of such private company are offered employment with such subsequent public transportation system without loss of compensation or benefits. The bill clarifies that the bill only applies to actions occurring on or after the effective date and excludes any action taken, contract signed, liability incurred, or right accrued prior to July 1, 2026, from the requirements. Finally, the bill directs the Director of the Department of Rail and Public Transportation to convene a work group to develop recommendations on how to implement the provisions of the bill and requires the work group to report its findings and recommendations to the Chairs of the House Committee on Labor and Commerce and Senate Committee on Local Government by November 1, 2026. This bill is identical to HB 547.
SB620 — Va. ABC Authority; permitting of retail tobacco product retailers, etc.
Virginia Alcoholic Beverage Control Authority; permitting of retail tobacco product retailers; purchase, possession, and sale of retail tobacco products; penalties; report. Transitions and provides a more comprehensive structure for the current licensing and enforcement responsibilities related to liquid nicotine and retail tobacco products from the Department of Taxation to a permitting system administered by the Virginia Alcoholic Beverage Control Authority. The bill requires the Board of Directors of the Virginia Alcoholic Beverage and Control Authority to conduct an unannounced buyer operation at least once every 24 months to verify that a permittee, defined in the bill, is not selling retail tobacco products to persons under 21 years of age. Portions of the bill have a delayed effective date of October 1, 2026. This bill is identical to HB 308.
SB666 — Residential land development and construction; fee transparency, local housing development.
Department of Housing and Community Development; housing development database. Requires the Department of Housing and Community Development to collect from each locality and make available to the public, localities, state agencies, and other state and regional public entities in a centralized, machine-readable, screen reader compatible database various data for each new and existing housing development in each locality in the Commonwealth, including data related to the number of housing development plans submitted and approved by the locality and the average approval timeline for housing development plans.
SB599 — Va. Opioid Use Red. & Jail-Based Substance Use Disorder Trtmt. and Transition Fund; grant procedure.
Virginia Opioid Use Reduction and Jail-Based Substance Use Disorder Treatment and Transition Fund; grant procedures. Requires the grant procedure to govern funds awarded to local and regional jails for the planning or operation of substance use disorder treatment services and transition services for persons with substance use disorder who are incarcerated in local and regional jails to include requirements that (i) any grant awarded shall be made for up to three years and (ii) an applicant for a grant submit a plan demonstrating how such applicant will become independently financially viable within the time period for which the grant is awarded. This bill is a recommendation of the Joint Commission on Health Care and is identical to HB 455.